Multiple ulcers and perforation of small intestine with everolimus use in a patient with rectal neuroendocrine tumor: A case report

INTRODUCTION: Everolimus is an orally administered inhibitor of the mammalian target of rapamycin, which is a serine/threonine protein kinase. It is used for the treatment of pancreatic and gastrointestinal neuroendocrine tumors (NETs). Gastrointestinal perforations in patients being treated with ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Kentaro, Emoto, Shigenobu, Sasaki, Kazuhito, Nozawa, Hiroaki, Yasunaga, Yoichi, Ishihara, Soichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139960/
https://www.ncbi.nlm.nih.gov/pubmed/37043898
http://dx.doi.org/10.1016/j.ijscr.2023.108094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139960/
https://www.ncbi.nlm.nih.gov/pubmed/37043898
http://dx.doi.org/10.1016/j.ijscr.2023.108094

Ejemplares similares